A Missouri judge on Friday, 20 November 2026, approved Bayer’s $7.25 billion settlement of lawsuits alleging that its weedkiller Roundup causes cancer, a decision that could ultimately resolve litigation that has weighed on the company for a decade.
Bayer faces about 65,000 claims in US state and federal courts from plaintiffs who say they developed cancer after using Roundup at home or at work. The settlement, announced in February, aims to resolve nearly all current and future Roundup claims in the United States.
Under the settlement, payouts range from $10,000 to $165,000 to people who were exposed to Roundup and developed non-Hodgkin lymphoma, depending on the severity of their illness, their age at diagnosis, and whether the exposure was at home or at work.
Bayer denies that Roundup causes cancer and says decades of studies show that glyphosate, its active ingredient, is safe.
The litigation has weighed on Bayer since its 2018 acquisition of Monsanto. Bayer previously spent about $10 billion in 2020 to resolve most of the Roundup lawsuits that existed at that time.
St. Louis Circuit Judge Timothy Boyer approved the deal, saying the average payouts are “fair and adequate” and the total is “among the largest in the history of mass tort personal-injury class action settlements”. The settlement is subject to appeal. Bayer chief executive Bill Anderson called it “a decisive milestone”.
The deal excludes lawsuits consolidated in an ongoing federal court proceeding, with about 200 cases still being litigated.
Source: Reuters


